Akorn, Inc. Announces Positive Phase III Pivotal Trial Results for Akten(R)
23 Enero 2007 - 6:00AM
Business Wire
Akorn, Inc. (AMEX: AKN) today announced the positive results of a
Phase III pivotal trial for Akten�. The clinical trial was a
randomized, placebo controlled, multi-centered, 4-arm trial in 209
subjects. The primary efficacy end point for achieving ocular
anesthesia (p
Safety First Trust Principal-Protected Trust Certificates Linked TO A U.S.-Europe-Japan Basket Structured Product (AMEX:AKN)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Safety First Trust Principal-Protected Trust Certificates Linked TO A U.S.-Europe-Japan Basket Structured Product (AMEX:AKN)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024
Real-Time news about Safety First Trust Principal-Protected Trust Certificates Linked TO A U.S.-Europe-Japan Basket Structured Product (American Stock Exchange): 0 recent articles
Más de Akorn, Inc. ArtÃculos de Noticias